!DOCTYPE html PUBLIC “-//W3C//DTD XHTML 1.1//EN” “http://www.w3.org/TR/xhtml11/DTD/xhtml11.dtd”>
CHAPTER 14 HISTAMINE ANTAGONISTS IN ACUTE ALLERGIC REACTION
Improved Outcomes in Patients with Acute Allergic Syndromes who are Treated with Combined H1 and H2 Antagonists
Lin RY, Curry A, Pesola GR, et al. Ann Emerg Med. 2000;36(5):462–468
BACKGROUND
H2-receptor antagonists were introduced as antacid medications in the late 1970s. Physicians started using H2-blockers to treat allergic reactions, based on the theoretical benefit of increased histamine blockade. Prior to this study, there had been evaluation of H2 blockade in preventing allergic reactions, but only one study had examined outcomes in treating patients with acute allergic reaction.
OBJECTIVES
To determine whether combined therapy with H1 and H2 antihistamines results in improved outcomes in patients with acute allergic symptoms.
METHODS
Randomized, double-blind, placebo-controlled trial conducted in a single urban academic ED between 1998 and 1999.